-
41
Developing multifactorial dementia prediction models using clinical variables from cohorts in the US and Australia
Published 2025-01-01“…This study used machine learning to re-examine the diagnostic potential of clinical measures for dementia. Data was sourced from the Australian Imaging, Biomarkers, and Lifestyle Flagship Study of Ageing (AIBL) and the Alzheimer’s Disease Neuroimaging Initiative (ADNI). …”
Get full text
Article -
42
Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review
Published 2024-12-01“…This literature review extensively analyzes NP2's role in these conditions, thereby highlighting its contributions to synaptic dysfunction, neuroinflammation, and neurotoxic protein aggregation. In Alzheimer's and Parkinson's diseases, NP2 is linked to amyloid-beta aggregation and dopaminergic neuron degeneration, respectively. …”
Get full text
Article -
43
-
44
Machine Learning Model-Based Applications for Food Management in Alzheimer’s Using Regression Analysis Approach
Published 2022-01-01“…Alzheimer’s disease (AD) has become a public health concern due to its misinterpretation with vascular dementia (VD) and mixed dementia Alzheimer’s disease (MXD). …”
Get full text
Article -
45
Effectiveness and utilization of a cognitive screening program for primary geriatric care
Published 2025-01-01Get full text
Article -
46
Relationship between Urinary Alzheimer-Associated Neuronal Thread Protein and Apolipoprotein Epsilon 4 Allele in the Cognitively Normal Population
Published 2020-01-01“…We investigated the relationship between urinary Alzheimer-associated neuronal thread protein (AD7c-NTP) levels and apolipoprotein epsilon 4 (ApoE ɛ4) alleles, as well as other factors that cause cognitive decline, in the cognitively normal population. …”
Get full text
Article -
47
Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives
Published 2016-01-01“…The management of neurodegenerative diseases such as Alzheimer’s disease (AD) and other dementias, Parkinson’s disease (PD) and PD related disorders, motor neuron diseases (MND), Huntington’s disease (HD), spinocerebellar ataxia (SCA), and spinal muscular atrophy (SMA), is mainly addressed to motor and cognitive impairment, with special care to vital functions as breathing and feeding. …”
Get full text
Article -
48
Development and validation of the Michigan Chronic Disease Simulation Model (MICROSIM).
Published 2024-01-01“…Strategies to prevent or delay Alzheimer's disease and related dementias (AD/ADRD) are urgently needed, and blood pressure (BP) management is a promising strategy. …”
Get full text
Article -
49
A Corticobasal Syndrome Variant of Familial Creutzfeldt-Jakob Disease with Stroke-Like Onset
Published 2016-01-01“…Creutzfeldt-Jakob disease (CJD) is an untreatable rare human prion disease characterized by rapidly progressive dementia along with various neurological features, including myoclonus and sometimes other movement disorders. …”
Get full text
Article -
50
Using Health Utility Index (HUI) for Measuring the Impact on Health-Related Quality of Life (HRQL) Among Individuals with Chronic Diseases
Published 2004-01-01“…Based on the Canadian Community Health Survey (CCHS) for 2000–01, the HUI was used to measure the quality of life for individuals living with various chronic conditions (Alzheimer/other dementia, effects of stroke, urinary incontinence, arthritis/rheumatism, bowel disorder, cataracts, back problems, stomach/intestinal ulcers, emphysema/COPD, chronic bronchitis, epilepsy, heart disease, diabetes, migraine headaches, glaucoma, asthma, fibromyalgia, cancers, high blood pressure, multiple sclerosis, thyroid condition, and other remaining chronic diseases). …”
Get full text
Article -
51
Clock-Drawing in Neurological Disorders
Published 1989-01-01“…Patients with probable Alzheimer's disease and other dementias have gross impairments in clock-drawing. …”
Get full text
Article -
52
Trends for Clinical Trials on Medicinal Products for Neurological Disorders in Lithuania and Europe
Published 2024-03-01“…The majority of the trials (363 (17.20%)) were clinical trials for Alzheimer’s disease and other dementias. During the period of 2012–2021, there was a significant decrease in the annual registration rate of clinical trials for Alzheimer’s disease and other dementias (R² = 0.751, p = 0.001) and an increase of clinical trials for myoneural junction and muscle diseases and motor neuron disease (R² = 0.582, p = 0.010 and R² = 0.635, p = 0.006, accordingly). …”
Get full text
Article -
53
Inflammatory biomarkers profiles and cognition among older adults
Published 2025-01-01Get full text
Article -
54
Research Progress and Trends in Exercise Interventions for Mild Cognitive Impairment: A Bibliometric Visualization Analysis Using CiteSpace
Published 2025-01-01“…After screening, 420 relevant publications were imported into CiteSpace6.3R2 for bibliometric analysis, generating visual maps of keywords, authors, institutions, and other key indicators.Results: Publications on exercise interventions for MCI have shown steady growth, with Journal of Alzheimer’s Disease leading in volume, and Geriatrics & Gerontology as the dominant subject area. …”
Get full text
Article -
55
Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia
Published 2023-01-01“…In addition to helping improve isolated insomnia, Suvorexant helps improve sleep in patients that have other comorbidities such as obstructive sleep apnea, Alzheimer's disease, dementia, acute stroke, and delirium. …”
Get full text
Article -
56
The Tree-Drawing Test (Koch’s Baum Test): A Useful Aid to Diagnose Cognitive Impairment
Published 2015-01-01“…Consecutive outpatients were classified as affected by dementia (Alzheimer’s disease (AD), frontotemporal dementia (FTD), and vascular dementia (VD)) or by MCI. …”
Get full text
Article -
57
Comorbidities among Patients with Epilepsy Attending Imam Al-Sadiq General Hospital in Babylon Governorate, Iraq
Published 2022-11-01“…Among psychiatric comorbidities, 67.1% of them were suffered from anxiety and 61.9% with depression. 7.6% of patient were suffering from Dementia/ Alzheimer’s disease as cognitive comorbidities. …”
Get full text
Article -
58